Resources from leading medical experts from UCSF Medical Center
The UCSF Helen Diller Family Comprehensive Cancer Center is the only center in the Bay Area to receive the prestigious designation of "comprehensive" from the National Cancer Institute. We treat all forms of cancer. With new facilities, expanded programs and innovative research, we help cancer patients live longer and fuller lives. The center ranks first in California and sixth nationwide in National Cancer Institute research grants, and is home to pioneers in research into genetic, cellular and immune system causes and responses to cancer.
Latest Videos |view all videos
Hematologist Nina Shah discusses the treatment plan of a patient diagnosed with a smoldering multiple myeloma (MM).
With the advent of immunotherapy, UCSF physicians are incorporating clinical trials into head and neck cancer patient care and changing the treatment paradigm.
Bonnie Joe, MD, PhD, discusses how breast MRI is performed, common indications for breast MRI and advanced methods for biopsy and pre-surgical localization of tumors.
Bonnie Joe, MD explains the differences between screening and diagnostic mammography, shows evidence for screening, answers common questions about radiation risk and false positives and discusses digital breast tomosynthesis, also known as 3D mammography.
Oncologist David Oh speaks at the October 2017 Bay Area Breast Cancer Forum about key developments in immunotherapy like immune checkpoint inhibitors and T-cell therapies, plus its use in experimental approaches to breast cancer treatment.
Discover the surprising way a simple surgery can vastly improve quality of life for head and neck cancer patients after radiation treatment. How? By moving the submandibular gland out of the way of the most intense radiation to prevent xerostomia.
Immunologist Michael Campbell and breast cancer surgeon Laura Esserman speak at the April 2017 Bay Area Breast Cancer Forum about the human biome, how it’s being studied and how it relates to breast cancer prevention and treatment.
Follow the journey of a UCSF patient with early-stage, high-risk lung cancer, from history to treatment and prognosis, including how surgeons chose to do a robotic assisted VATS lobectomy and an analysis of how well chemo is likely to work for her.
A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope Rugo
Specialized treatments for acute and chronic blood conditions, from cancers to the full range of non-malignant blood disorders
Expert care to improve both survival and quality of life
Highly specialized care for patients with melanoma, Merkel Cell and other skin cancers
UCSF is a leader in the newest forms of cellular immunotherapy, which have been shown to be particularly effective in the treatment of B-cell non-Hodgkin lymphoma (NHL) and B-cell acute lymphoblastic leukemia (B-ALL).
Expert care and transformative research working together to improve both survival and quality of life
featuring surgeons who are subspecialty-trained and leaders in the field of endocrine surgery
UCSF Health offers a robotic thoracic surgery program specializing in treating thoracic disease.